retatrutide phase 2 trial type 2 diabetes weight loss Retatrutide, a TRIPLE agonist (GLP1, GIP, glucagon), just released results demonstrating 25% in half of people with #obesity. This amount of weight loss has not been accomplished VisualAbstract: Retatrutide reduces body weight

they have been around in some form for 20 years

Unreconstituted Retatrutide requires refrigeration at 2-8 degrees Celsius

This approach costs more per milligram upfront but prevents the much larger cost of purchasing bulk quantities from a vendor whose quality turns out to be substandard

And while its always best to get these nutrients from food, supplements can help fill in the gaps, especially when your appetite is tamped down

While neither liraglutide nor semaglutide is FDA-approved for cardiovascular protection, research suggests both may help lower the risk of major heart-related events like heart attack, stroke, or cardiovascular death in people with type 2 diabetes

As confidence increases, using that confidence to strengthen social connections creates positive feedback